Last Update 22 Jun 26
Fair value Increased 84%AIP: Elevated AI Licensing Optimism Will Likely Limit Forward Return Potential
Arteris' analyst price target has moved from $20.50 to about $38, reflecting analysts' updated views after beat and raise results, stronger data center and AI related licensing momentum, and expectations for earlier and higher royalty contributions compared with prior assumptions tied more heavily to automotive.
Analyst Commentary
Recent research updates on Arteris center on its latest beat and raise quarter, the growing importance of data center and AI related licensing, and how quickly this mix could translate into royalty revenue compared with earlier expectations tied more heavily to automotive.
Bullish Takeaways
- Bullish analysts highlight the beat and raise quarter as a sign that Arteris is executing ahead of prior expectations, which they see as supporting higher valuation multiples.
- Several reports point to data center and AI related licenses becoming the largest licensing vertical. Analysts link this to faster royalty realization and higher average selling prices, supporting stronger top line potential than earlier auto centric assumptions.
- Early data center license wins are viewed as pulling forward royalty contributions relative to automotive. Bullish analysts see this as improving visibility into future revenue streams.
- Royalty trends are described as improving meaningfully. Greater exposure to data center activity is seen as a key driver of Arteris’ growth profile and analysts’ higher price targets in the US$35 to US$40 range.
Bearish Takeaways
- More cautious analysts point to a step up in spending and want better clarity on Arteris’ path to profitability before becoming more constructive on the stock.
- The shift toward data center and AI related demand is viewed as positive for growth, but some research flags execution risk around converting this pipeline into sustained, profitable royalty revenue.
- While beat and raise results underpin the recent price target increases, bearish analysts stress that valuation now embeds higher expectations for continued performance, leaving less room for operational missteps.
What’s in the News for Arteris
- Arteris has been in focus after recent stock momentum tied to demand for its network on chip interconnect technology used in complex AI semiconductor processors and advanced automotive chips, according to recent news reports.
- Recent coverage highlights multiple demand drivers for Arteris, including accelerating AI chip design activity, rising semiconductor complexity, and the shift toward chiplet based and 3D stacked architectures, with some analysts viewing the stock as overvalued relative to their fair value estimates. Source: Recent news reports.
- Arteris system IP technology has been deployed by Li Auto for proprietary system on chips in its L9 Livis high tech SUV, where FlexNoC 5 and Magillem software are used to support AI compute data movement, energy efficiency targets, and functional safety requirements. Source: Company client announcement.
- The company announced that Renesas has licensed and deployed Arteris FlexNoC interconnect IP for its R Car Gen 5 SoC series and chiplet extensions, which are intended for future AI enabled autonomous vehicle platforms. Source: Company client announcement.
- Arteris disclosed a collaboration with MIPS, a GlobalFoundries company, as MIPS selected Arteris FlexGen smart NoC IP and Magillem SoC integration software to support physical AI computing platforms for markets such as automotive MCUs, ADAS, robotics, and embedded computing. Source: Company client announcement.
Valuation Changes for Arteris
- Fair Value: The updated analyst fair value estimate has risen from $20.50 to $37.75, roughly 84% higher than the prior figure.
- Discount Rate: The discount rate has moved slightly higher from 8.46% to about 8.57%, indicating a modest change in the risk assumptions used in valuation models.
- Revenue Growth: Assumed long term revenue growth has been revised from about 22.86% to roughly 25.28%, reflecting a somewhat higher growth outlook in analyst models for Arteris.
- Net Profit Margin: The expected net profit margin has shifted from approximately 11.45% to around 12.11%, implying a small uplift in forecasted profitability over time.
- Future P/E: The future P/E multiple has moved from about 96x to roughly 148x, indicating that updated models apply a higher earnings multiple to Arteris compared with the previous set of assumptions.
Key Takeaways
- Rising AI adoption and industry shifts toward chiplet architectures are expanding Arteris' market opportunities and supporting sustained revenue growth.
- Innovative product launches and stronger customer reliance are boosting competitive advantage, recurring revenues, and margin expansion potential.
- Dependence on large customers, rising R&D costs, and evolving industry dynamics threaten revenue stability, profitability, and long-term growth amid ongoing macroeconomic uncertainties.
Catalysts
About Arteris- Provides semiconductor system intellectual property solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia Pacific, Europe, and the Middle East.
- Accelerating adoption of AI and machine learning in enterprise computing and automotive sectors is driving higher demand for Arteris' advanced NoC IP, as evidenced by recent major wins like AMD and Whalechip; this is likely to underpin sustained revenue growth as AI workloads and system complexity proliferate across industries.
- The ongoing industry transition to chiplet-based and heterogeneous integration architectures is expanding Arteris' addressable market, with chiplet-related design starts expected to rise from 5% to 30% in coming years; this structural trend supports both higher sales volume and increased average selling prices, benefiting future top-line revenue.
- Arteris' launch of innovative products such as FlexGen and Magillem Packaging-recognized with industry awards and integrated into leading chipmaker portfolios-raises the technological moat, improving competitive positioning and enabling potential margin expansion through pricing power.
- Increasing reliance by large semiconductor companies on outsourcing specialized system IP, highlighted by growing customer interest and accelerated engagements, suggests expanding recurring revenue streams and enhanced revenue visibility, which may drive more stable and predictable long-term earnings.
- Growth in remaining performance obligations (RPO), up 28% year-over-year, signals a solid and expanding contractual revenue base, providing confidence in forward revenue realization and supporting operating leverage as R&D investments start to scale with increased deployment of Arteris' solutions.
Arteris Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Arteris's revenue will grow by 25.3% annually over the next 3 years.
- Analysts are not forecasting that Arteris will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Arteris's profit margin will increase from -44.9% to the average US Software industry of 12.1% in 3 years.
- If Arteris's profit margin were to converge on the industry average, you could expect earnings to reach $18.3 million (and earnings per share of $0.32) by about June 2029, up from -$34.6 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting $26.9 million in earnings, and the most bearish expecting $-6.7 million.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 149.1x on those 2029 earnings, up from -58.9x today. This future PE is greater than the current PE for the US Software industry at 25.9x.
- Analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 8.57%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Arteris continues to operate at a net loss and projects a non-GAAP operating loss for the full year 2025 ($10.5 to $15.5 million), indicating ongoing challenges in achieving profitability and potential pressure on earnings and net margins if revenue growth falters or costs escalate.
- The high concentration of large whale deals (such as the recent AMD agreement) exposes Arteris to customer concentration risk; if major customers reduce outsourcing, insource NoC IP, or switch providers, future revenues and cash flows could become volatile.
- The increasing scale of R&D and field engineering investments, combined with only a gradual ramp in new product adoption, raises the risk that operating costs will outpace revenue growth, which could further suppress margins and delay a path to sustainable earnings.
- The expansion of chiplet and heterogeneous integration technologies by mega-customers (like AMD using its own Infinity Fabric for coherent data, and only using Arteris for non-coherent applications) could lead to competitors or major chipmakers developing proprietary NoC solutions, diminishing Arteris' external market and negatively impacting long-term revenue growth.
- Macroeconomic uncertainty (including FX fluctuations, global economic conditions, and possible geopolitical headwinds) can impact deal flow, OpEx (as seen recently with unfavorable USD/EUR movements), and delay sales cycles, all of which add risk to revenue predictability and margin expansion over time.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of $37.75 for Arteris based on their expectations of its future earnings growth, profit margins and other risk factors.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $151.4 million, earnings will come to $18.3 million, and it would be trading on a PE ratio of 149.1x, assuming you use a discount rate of 8.6%.
- Given the current share price of $44.11, the analyst price target of $37.75 is 16.8% lower. Despite analysts expecting the underlying business to improve, they seem to believe the market's expectations are too high.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Arteris?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.